Cargando…
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Parkinson's disease (PD), known as one of the most universal neurodegenerative diseases, is a serious threat to the health of the elderly. The current treatment has been demonstrated to relieve symptoms, and the discovery of new small-molecule compounds has been regarded as a promising strategy...
Autores principales: | Zhang, Kai, Zhu, Shiou, Li, Jiamei, Jiang, Tingting, Feng, Lu, Pei, Junping, Wang, Guan, Ouyang, Liang, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546670/ https://www.ncbi.nlm.nih.gov/pubmed/34729301 http://dx.doi.org/10.1016/j.apsb.2021.02.016 |
Ejemplares similares
-
ACTP: A webserver for predicting potential targets and relevant pathways of autophagy-modulating compounds
por: Xie, Tao, et al.
Publicado: (2016) -
Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose
por: Li, Jingjing, et al.
Publicado: (2015) -
Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
por: Pan, Xiaoli, et al.
Publicado: (2022) -
Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
por: Zhang, Lijuan, et al.
Publicado: (2022) -
Small molecules targeting protein–protein interactions for cancer therapy
por: Wu, Defa, et al.
Publicado: (2023)